
Work Here?
RightEye develops an FDA-cleared eye-tracking platform that records and analyzes eye movements to assess vision and brain health. Patients complete five-minute, game-like tests on a screen while the system collects data and generates a report that compares results to normative data. The platform is used by optometrists, hospitals, and professional sports teams for concussion screening, functional vision assessment, and early detection of conditions like Parkinson's disease. Its goal is to replace subjective observations with objective, quantitative measurements to improve diagnosis, monitoring, and outcomes.
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
11-50
Company Stage
Debt Financing
Total Funding
$13.4M
Headquarters
Bethesda, Maryland
Founded
2012
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$13.3M
Above
Industry Average
Funded Over
6 Rounds
Indepthvision recently purchased the Right Eye, an innovative eye-tracking technology that allows Indepthvision to assess eye movements and track reaction times accurately.
RightEye, the world’s leading eye-tracking biomarker company, has signed a research collaboration agreement with the Massachusetts Institute of Technology (MIT) to study an oculomotor “signature” for Lyme disease.
RightEye LLC, an eye-tracking technology company, has launched an automated, quantitative sensorimotor exam system.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
11-50
Company Stage
Debt Financing
Total Funding
$13.4M
Headquarters
Bethesda, Maryland
Founded
2012
Find jobs on Simplify and start your career today